30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease (vol 122, pg 165, 2018)

被引:0
|
作者
Osti, M. F. [1 ]
Agolli, L. [2 ,3 ]
Valeriani, M. [1 ]
Reverberi, C. [1 ]
Braccia, S. [1 ]
Marinelli, L. [1 ]
De Sanctis, V. [1 ]
Cortesi, E. [4 ]
Martelli, M. [5 ]
De Dominicis, C. [6 ]
Minniti, G. [7 ,8 ]
Nicosia, L. [1 ]
机构
[1] Sapienza Univ Rome, St Andrea Hosp, Dept Radiat Oncol, Rome, Italy
[2] Tech Univ Dresden, Fac Med, Dept Radiat Oncol, Dresden, Germany
[3] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[4] Sapienza Univ Rome, Policlin Umberto 1, Dept Radiol Oncol & Human Pathol, Rome, Italy
[5] Carlo Forlanini Hosp, Thorac Surg Unit, Rome, Italy
[6] Sapienza Univ Rome, St Andrea Hosp, Dept Radiol, Rome, Italy
[7] IRCCS Neuromed, Dept Neurol Sci, Via Atinense, Pozzilli, IS, Italy
[8] UPMC San Pietro FBF, Radiotherapy Ctr, Rome, Italy
关键词
D O I
10.1016/j.lungcan.2021.05.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:168 / 168
页数:1
相关论文
共 50 条
  • [1] 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease
    Osti, M. F.
    Agolli, L.
    Valeriani, M.
    Reverberi, C.
    Bracci, S.
    Marinelli, L.
    De Sanctis, V.
    Cortesi, E.
    Martelli, M.
    De Dominicis, C.
    Minniti, G.
    Nicosia, L.
    LUNG CANCER, 2018, 122 : 165 - 170
  • [2] 30 Gy single dose SBRT: Outcome in a large series of patients with lung oligometastatic disease
    Nicosia, L.
    Agolli, L.
    Valeriani, M.
    Reverberi, C.
    Bracci, S.
    Marinelli, L.
    De Sanctis, V.
    Cortesi, E.
    Martelli, M.
    De Dominicis, C.
    Osti, M. F.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S403 - S404
  • [3] Lung metastases in oligometastatic patients: outcome with stereotactic body radiation therapy (SBRT)
    S. García-Cabezas
    C. Bueno
    E. Rivin
    J. M. Roldán
    A. Palacios-Eito
    Clinical and Translational Oncology, 2015, 17 : 668 - 672
  • [4] Lung metastases in oligometastatic patients: outcome with stereotactic body radiation therapy (SBRT)
    Garcia-Cabezas, S.
    Bueno, C.
    Rivin, E.
    Roldan, J. M.
    Palacios-Eito, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (08): : 668 - 672
  • [5] 30 Gy single dose stereotactic radiation therapy in a series of patients with lung oligometastasis
    Anzellini, D.
    Scalabrino, G.
    Campanella, B.
    Perrone, F.
    Ascolese, A. M.
    Valeriani, M.
    Osti, M. F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S970 - S970
  • [6] 30 Gy single-dose SBRT to lung lesions: outcome in a large series of patients
    Nicosia, L.
    Reverberi, C.
    Agolli, L.
    Valeriani, M.
    De Sanctis, V.
    De Dominicis, C.
    Minniti, G.
    Cortesi, E.
    Martelli, M.
    Osti, M. F.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S348 - S349
  • [7] Outcome of Lung Metastases Receiving & lt; 30 Gy Stereotactic Body Radiation Therapy in a Single Fraction
    Lloyd, S.
    Descovich, M.
    Sudhyadhom, A.
    Yom, S.
    Gottschalk, A.
    Braunstein, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S762 - S762
  • [8] Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
    Sabine Gerum
    Christian Heinz
    Claus Belka
    Franziska Walter
    Philipp Paprottka
    Enrico N. De Toni
    Falk Roeder
    Radiation Oncology, 13
  • [9] Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
    Gerum, Sabine
    Heinz, Christian
    Belka, Claus
    Walter, Franziska
    Paprottka, Philipp
    De Toni, Enrico N.
    Roeder, Falk
    RADIATION ONCOLOGY, 2018, 13
  • [10] Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study
    Burkon, P.
    Kazda, T.
    Pospisil, P.
    Slavik, M.
    Kominek, L.
    Selingerova, I
    Blakaj, D. M.
    Prochazka, T.
    Vrzal, M.
    Rehak, Z.
    Slampa, P.
    NEOPLASMA, 2019, 66 (02) : 315 - 325